Octagon Capital Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,551,703
| Closed | -$59.1M | – | 45 |
|
|
2023
Q1 | $59.1M | Hold |
2,551,703
| – | – | 8.5% | 2 |
|
|
2022
Q4 | $66.9M | Hold |
2,551,703
| – | – | 10.41% | 2 |
|
|
2022
Q3 | $50.2M | Hold |
2,551,703
| – | – | 8.66% | 3 |
|
|
2022
Q2 | $44.6M | Buy |
2,551,703
+1,195,453
| +88% | +$20.9M | 11.91% | 3 |
|
|
2022
Q1 | $22.2M | Buy |
1,356,250
+856,250
| +171% | +$14M | 4.8% | 7 |
|
|
2021
Q4 | $8.16M | Buy |
+500,000
| New | +$8.16M | 1.59% | 15 |
|